Literature DB >> 10235424

Structural and functional basis of plasminogen activation by staphylokinase.

L Jespers1, S Vanwetswinkel, H R Lijnen, N Van Herzeele, B Van Hoef, E Demarsin, D Collen, M De Maeyer.   

Abstract

Staphylokinase (Sak), a 15.5-kDa bacterial protein, forms a complex with human plasmin, which in turn activates other plasminogen molecules to plasmin. Three recombinant DNA-based approaches, (i) site directed substitution with alanine, (ii) search for proximity relationships at the complex interface, and (iii) active-site accessibility to protease inhibitors have been used to deduce a coherent docking model of the crystal structure of Sak on the homology-based model of microplasmin (microPli), the serine protease domain of plasmin. Sak binding on microPli is primarily mediated by two surface-exposed loops, loops 174 and 215, at the rim of the active-site cleft, while the binding epitope of Sak on microPli involves several residues located in the flexible NH2-terminal arm and in the five-stranded mixed beta-sheet. Several Sak residues located within the unique alpha-helix and the beta2 strand do not contribute to the binding epitope but are essential to induce plasminogen activating potential in the Sak:microPli complex. These residues form a topologically distinct activation epitope, which, upon binding of Sak to the catalytic domain of microPli, protrudes into a broad groove near the catalytic triad of microPli, thereby generating a competent binding pocket for micro-plasminogen (microPlg), which buries approximately 2500 A of the Sak:microPli complex upon binding. This structural and functional model may serve as a template for the design of improved Sak-derived thrombolytic agents. Following the completion and presentation of the present study, the deduced Sak:microPli:microPlg complex was fully confirmed by X-ray crystallography, which further illustrates the power and potential of the present approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235424

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation.

Authors:  Karen G Wiles; Peter Panizzi; Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

Review 3.  Current state of thrombolytic therapy.

Authors:  D A Vorchheimer
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

Review 4.  Proteases as therapeutics.

Authors:  Charles S Craik; Michael J Page; Edwin L Madison
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

5.  Function of the 90-loop (Thr90-Glu100) region of staphylokinase in plasminogen activation probed through site-directed mutagenesis and loop deletion.

Authors:  Govindan Rajamohan; Monika Dahiya; Shekhar C Mande; Kanak L Dikshit
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

6.  Rat cerebral ischemia induced with photochemical occlusion of proximal middle cerebral artery: a stroke model for MR imaging research.

Authors:  Feng Chen; Yasuhiro Suzuki; Nobuo Nagai; Ronald Peeters; Xihe Sun; Walter Coudyzer; Guy Marchal; Yicheng Ni
Journal:  MAGMA       Date:  2004-10-26       Impact factor: 2.310

7.  Molecular insight into the steric shielding effect of PEG on the conjugated staphylokinase: biochemical characterization and molecular dynamics simulation.

Authors:  Qimeng Mu; Tao Hu; Jingkai Yu
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.